Lubbe Wiesner
Lubbe Wiesner
Associate Professor of Pharmacology, University of Cape Town
Verified email at uct.ac.za
Title
Cited by
Cited by
Year
Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection
KE Dooley, P Denti, N Martinson, S Cohn, F Mashabela, J Hoffmann, ...
The Journal of infectious diseases 211 (2), 197-205, 2015
862015
Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis
S Thee, AJ Garcia-Prats, HR Draper, HM McIlleron, L Wiesner, S Castel, ...
Clinical Infectious Diseases 60 (4), 549-556, 2015
682015
Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients
T Kredo, K Mauff, JS Van der Walt, L Wiesner, G Maartens, K Cohen, ...
Antimicrobial agents and chemotherapy 55 (12), 5616-5623, 2011
672011
Pharmacokinetics of isoniazid, pyrazinamide, and ethambutol in newly diagnosed pulmonary TB patients in Tanzania
P Denti, K Jeremiah, E Chigutsa, D Faurholt-Jepsen, G PrayGod, ...
PloS one 10 (10), e0141002, 2015
582015
Progress towards the UNAIDS 90–90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey
H Huerga, G Van Cutsem, JB Farhat, A Puren, M Bouhenia, L Wiesner, ...
BMC public health 18 (1), 1-8, 2018
552018
Drug–drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB
M Pandie, L Wiesner, H McIlleron, J Hughes, S Siwendu, F Conradie, ...
Journal of Antimicrobial Chemotherapy 71 (4), 1037-1040, 2016
552016
Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV
K Jeremiah, P Denti, E Chigutsa, D Faurholt-Jepsen, G PrayGod, ...
Antimicrobial agents and chemotherapy 58 (6), 3468-3474, 2014
552014
Pharmacokinetics of rifampin, isoniazid, pyrazinamide, and ethambutol in infants dosed according to revised WHO-recommended treatment guidelines
A Bekker, HS Schaaf, HR Draper, L van der Laan, S Murray, L Wiesner, ...
Antimicrobial agents and chemotherapy 60 (4), 2171-2179, 2016
542016
Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children
S Thee, AJ Garcia-Prats, HM McIlleron, L Wiesner, S Castel, J Norman, ...
Antimicrobial agents and chemotherapy 58 (5), 2948-2951, 2014
522014
Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug …
V Johnston, K Cohen, L Wiesner, L Morris, J Ledwaba, KL Fielding, ...
The Journal of infectious diseases 209 (5), 711-720, 2014
522014
Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy
MN Aminake, A Mahajan, V Kumar, R Hans, L Wiesner, D Taylor, ...
Bioorganic & medicinal chemistry 20 (17), 5277-5289, 2012
492012
Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures
KEJ Brunette, BJ Anderson, J Thomas, L Wiesner, DW Herd, S Schulein
Pediatric Anesthesia 21 (6), 653-662, 2011
482011
Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in …
E Davlantes, PR Dimbu, CM Ferreira, MF Joao, D Pode, J Félix, ...
Malaria journal 17 (1), 1-11, 2018
452018
Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment
AA Kim, I Mukui, PW Young, J Mirjahangir, S Mwanyumba, J Wamicwe, ...
Aids 30 (17), 2685-2695, 2016
452016
Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
H Moultrie, H McIlleron, S Sawry, T Kellermann, L Wiesner, G Kindra, ...
Journal of Antimicrobial Chemotherapy 70 (2), 543-549, 2015
452015
Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium (II) and rhodium (III) thiosemicarbazone complexes
M Adams, C de Kock, PJ Smith, KM Land, N Liu, M Hopper, A Hsiao, ...
Dalton Transactions 44 (5), 2456-2468, 2015
452015
Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1
C Le Manach, D Gonzàlez Cabrera, F Douelle, AT Nchinda, Y Younis, ...
Journal of medicinal chemistry 57 (6), 2789-2798, 2014
432014
Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis
E Chigutsa, S Meredith, L Wiesner, N Padayatchi, J Harding, P Moodley, ...
Antimicrobial agents and chemotherapy 56 (7), 3857-3863, 2012
422012
Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients
SP Zvada, P Denti, FA Sirgel, E Chigutsa, M Hatherill, S Charalambous, ...
Antimicrobial agents and chemotherapy 58 (1), 503-510, 2014
412014
Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technology
JD Steyn, L Wiesner, LH Du Plessis, AF Grobler, PJ Smith, WC Chan, ...
International journal of pharmaceutics 414 (1-2), 260-266, 2011
412011
The system can't perform the operation now. Try again later.
Articles 1–20